PMV PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
PMV PHARMACEUTICALS, INC. (PMVP) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value of $0.00 per share as of 2025-12-31, per its 10-K filed 2026-03-06.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue · last filed 2026-03-06
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $0.00.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $0.00.
- 2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $0.00.
- 2025-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $1.80.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value as first filed |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-06 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $1.80 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $1.80 10-K · filed 2026-03-06 | |
| 2024-09-30 | $1.80 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $4.18 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $4.18 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $13.62 10-K · filed 2025-03-03 | $13.60 10-K · filed 2024-02-29 |
| 2023-09-30 | $13.60 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $13.60 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $13.60 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $13.60 10-K · filed 2024-02-29 | |
| 2022-09-30 | $13.60 10-Q · filed 2022-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |